Select Medical Holdings Co. (NYSE:SEM) Shares Bought by Royce & Associates LP

Royce & Associates LP boosted its holdings in shares of Select Medical Holdings Co. (NYSE:SEM) by 0.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 346,675 shares of the health services provider’s stock after acquiring an additional 1,910 shares during the quarter. Royce & Associates LP owned about 0.27% of Select Medical worth $12,089,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD grew its stake in shares of Select Medical by 0.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,202,219 shares of the health services provider’s stock valued at $518,647,000 after buying an additional 90,604 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Select Medical by 5.3% in the first quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after buying an additional 650,093 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Select Medical by 2.2% in the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock valued at $157,728,000 after buying an additional 95,578 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after buying an additional 147,032 shares in the last quarter. Finally, Victory Capital Management Inc. grew its stake in shares of Select Medical by 0.6% in the third quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after buying an additional 7,372 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Trading Up 0.6 %

NYSE:SEM opened at $37.45 on Friday. The stock has a 50-day simple moving average of $34.81 and a 200-day simple moving average of $34.73. The stock has a market cap of $4.85 billion, a P/E ratio of 17.50, a P/E/G ratio of 1.95 and a beta of 1.42. Select Medical Holdings Co. has a 1 year low of $22.26 and a 1 year high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last announced its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business’s revenue was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.46 EPS. As a group, analysts anticipate that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be given a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.34%. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on SEM. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a report on Wednesday. Bank of America began coverage on Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price for the company. Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Benchmark reiterated a “buy” rating and issued a $48.00 target price on shares of Select Medical in a report on Friday, November 1st. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Select Medical currently has a consensus rating of “Moderate Buy” and an average target price of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.